Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Young

Showing results (491-500 of 3,265) with videos related to

Pageof 327
Sort By:
Cancer Treatment Reports|August 1, 1979
Phase II trial of pyrazofurin, alone and in combination with trifluorothymidine, in non-Hodgkin's lymphomaR P Warrell, V Currie, S Kempin, et al.
Plant Physiology|February 13, 2001
Efficient screening of Arabidopsis T-DNA insertion lines using degenerate primersJ C Young, P J Krysan, M R Sussman
Journal of Bacteriology|September 1, 1990
Nutrient-dependent methylation of a membrane-associated protein of Escherichia coliC C Young, J D Alvarez, R W Bernlohr
Gut Microbes|May 5, 2012
Infection strategies of enteric pathogenic Escherichia coliAbigail Clements, Joanna C Young, Nicholas Constantinou, et al.
Drugs|October 1, 1985
Current management of Hodgkin's diseaseB C Behrens, R C Young, V T DeVita
Science (New York, N.Y.)|July 24, 1970
Pion cancer therapy: positron activity as an indicator of depth-doseM C Taylor, G C Phillips, R C Young
Life Sciences|January 1, 1992
Skeletal muscle glucose uptake following overload-induced hypertrophyJ C Young, S C Kandarian, T G Kurowski
Convulsive Therapy|January 1, 1989
ECT in the High-Risk Geriatric PatientGeorge S. Alexopoulos, Robert C. Young, Robert C. Abrams
Journal of Toxicology and Environmental Health|May 1, 1981
How good are the numbers for cigarette tar at predicting deliveries of carbon monoxide, hydrogen cyanide, and acrolein?J C Young, J C Robinson, W S Rickert
American Journal of Obstetrics and Gynecology|November 1, 1981
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implicationsC E Ehrlich, P C Young, R E Cleary
Pageof 327

Showing results (491-500 of 3,265) with videos related to

Sort By:
Pageof 327
Cancer Treatment Reports|August 1, 1979
Phase II trial of pyrazofurin, alone and in combination with trifluorothymidine, in non-Hodgkin's lymphomaR P Warrell, V Currie, S Kempin, et al.
Plant Physiology|February 13, 2001
Efficient screening of Arabidopsis T-DNA insertion lines using degenerate primersJ C Young, P J Krysan, M R Sussman
Journal of Bacteriology|September 1, 1990
Nutrient-dependent methylation of a membrane-associated protein of Escherichia coliC C Young, J D Alvarez, R W Bernlohr
Gut Microbes|May 5, 2012
Infection strategies of enteric pathogenic Escherichia coliAbigail Clements, Joanna C Young, Nicholas Constantinou, et al.
Drugs|October 1, 1985
Current management of Hodgkin's diseaseB C Behrens, R C Young, V T DeVita
Science (New York, N.Y.)|July 24, 1970
Pion cancer therapy: positron activity as an indicator of depth-doseM C Taylor, G C Phillips, R C Young
Life Sciences|January 1, 1992
Skeletal muscle glucose uptake following overload-induced hypertrophyJ C Young, S C Kandarian, T G Kurowski
Convulsive Therapy|January 1, 1989
ECT in the High-Risk Geriatric PatientGeorge S. Alexopoulos, Robert C. Young, Robert C. Abrams
Journal of Toxicology and Environmental Health|May 1, 1981
How good are the numbers for cigarette tar at predicting deliveries of carbon monoxide, hydrogen cyanide, and acrolein?J C Young, J C Robinson, W S Rickert
American Journal of Obstetrics and Gynecology|November 1, 1981
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implicationsC E Ehrlich, P C Young, R E Cleary
Pageof 327